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MaOBJECTIVES This study sought to prove the safety and effectiveness of pressure-wire-guided percutaneous translu-
minal pulmonary angioplasty (PTPA).
BACKGROUND PTPA has been demonstrated to be effective for treatment of chronic thromboembolic pulmonary
hypertension. However, a major and occasionally fatal complication after PTPA is reperfusion pulmonary edema. To avoid
this, we developed the PEPSI (Pulmonary Edema Predictive Scoring Index). The pressure wire has been used to detect
insufﬁciency of ﬂow in a vessel.
METHODS We included 350 consecutive PTPA sessions in 103 patients with chronic thromboembolic pulmonary
hypertension from January 1, 2009 to December 31, 2013. During these 5 years, 140 PTPA sessions were performed
without guidance, 65 with guidance of PEPSI alone, and 145 with both PEPSI and pressure-wire guidance. Each PTPA
session was ﬁnished after achieving PEPSI scores of <35.4 with PEPSI guidance and each target lesion achieving distal
mean pulmonary arterial pressure <35 mm Hg with pressure-wire guidance.
RESULTS The occurrence of clinically critical reperfusion pulmonary edema and vessel injuries were lowest in the group
using the guidance of both pressure wire and PEPSI (0% and 6.9%, respectively). Furthermore, the group guided by
pressure wire and PEPSI accomplished the same hemodynamic improvements with fewer numbers of target lesions
treated and sessions performed.
CONCLUSIONS The combined approach using pressure wire and PEPSI produced more efﬁcient clinical results
and greatly reduced reperfusion pulmonary edema and vessel complications. This is further evidence that PTPA
is an alternative strategy for treating chronic thromboembolic pulmonary hypertension. (J Am Coll Cardiol Intv
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ABBR EV I A T I ON S
AND ACRONYMS
6MWD = six-minute-walk
distance
BNP = B-type natriuretic
peptide
CTEPH = chronic
thromboembolic pulmonary
hypertension
IQR = interquartile range
PAP = pulmonary arterial
pressure
PEPSI = Pulmonary Edema
Predictive Scoring Index
PTPA = percutaneous
transluminal pulmonary
angioplasty
PVR = pulmonary vascular
resistance
RPE = reperfusion pulmonary
edema
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1298and mortality (1–3). That is the main reason
this less invasive, useful strategy has not pro-
gressed and has been suspended for a long
time.
In 2001, Feinstein et al. (1) ﬁrst reported the
results of pulmonary balloon angioplasty in a
collective group of patients, in which he
showed that 11 of 18 patients (61%) developed
RPE after balloon pulmonary angioplasty. In
our previous report, based on our initial ex-
periences, 27 of 51 cases (53%) developed RPE,
and the patients with more severe clinical
signs and/or hemodynamic abnormalities at
baseline had a higher risk of RPE (2). Impor-
tantly, we recently demonstrated the use-
fulness of the PEPSI (Pulmonary Edema
Predictive Scoring Index) as a promising pre-
dictor to avoid signiﬁcant RPE (3). If the
endpoint per each PTPA session were deter-
mined with PEPSI scores of <35.4, the nega-tive predictive value of RPE would be 92.3% (3).
However, PEPSI is calculated by pulmonary ﬂow grade
scoring (grades 0, 1, 2, and 3), the determination of
which needs subjective judgment based on pulmonary
arterial and venous ﬂows (3). Therefore, an additional
new objective tool to avoid signiﬁcant RPE has long
been desired.
The mean pulmonary arterial pressure (PAP) is
normally <25 mm Hg. It has been reported that devel-
opment of RPE correlates with mean PAP >35 mm Hg
before angioplasty (1). In our experience, the median
value of mean PAP before angioplasty in cases without
RPE was 33 mm Hg (3). These ﬁndings suggest that
if the pulmonary peripheral arteries are suddenly
exposed to pressure >33 mm Hg, RPE would ensue
through their capillary permeability. Therefore, we
hypothesized that if the pressure level of the vascula-
tures distal to the target lesions after angioplasty can
be measured accurately, and if its level can be regu-
lated <35 mm Hg, then PTPA will be performed safely
without risk of RPE. To clarify this hypothesis, we have
begun using a pressure-wire-guided technique. The
pressure wire can measure the proximal and distal
pressures across the target lesions in addition to
serving as a guidewire to insert balloon catheters.
Furthermore, if the PTPA procedures are performed
under guidance of a pressure wire, vessel injuries due
to overdilation by balloon catheters or wire
perforations will be reduced, leading to safer PTPA
procedures.
Therefore, the purposes of this study were as
follow: 1) to clarify the efﬁcacy in hemodynamic
improvement; and 2) to evaluate the prevalence of
the complications, including RPE and vessel injuries,in our recent procedures, in which both the PEPSI and
pressure-wire-guided techniques have been used, in
comparison with those in our initial procedures
without those techniques. If these approaches prove
to be effective, they will contribute signiﬁcantly to
efﬁcient and safe performance of PTPA even in less-
experienced institutions all over the world.
METHODS
STUDY DESIGN. From January 2009 to December
2013, 350 consecutive PTPA sessions were performed
on the 103 patients with CTEPH who were enrolled
at Keio University Hospital or Kyorin University
Hospital in Japan. The patients were diagnosed with
CTEPH by demonstration of organized pulmonary
thromboembolism using contrast-enhanced lung
computed tomography, perfusion lung scintigraphy,
and pulmonary angiography and ruling out collagen
vascular disease, pulmonary disease, left heart ab-
normality, and other systemic diseases by blood tests,
pulmonary function tests, and echocardiography. All
patients provided written informed consent, and the
performance of PTPA and analysis of clinical data in
the present study were approved by the institutional
review boards of Kyorin University Hospital and Keio
University Hospital. Some of the enrolled patients
and a portion of the data used for analysis in this
study are the same as in our previous reports (2–6).
EXAMINATIONS. Patients underwent right-sided
heart catheterization just before and after PTPA and
at the follow-up examinations. Follow-up right-sided
heart catheterization after the last procedure was
performed at 3 to 6 months and at 12 months, and
every year thereafter. Right atrial pressure, PAP, and
pulmonary arterial wedge pressure were measured at
the right-sided heart catheterization. Cardiac output
was determined by the Fick technique using assumed
oxygen consumption. Cardiac index was calculated
by dividing cardiac output by body surface area.
Pulmonary vascular resistance (PVR) was calculated
by subtracting the pulmonary arterial wedge pressure
from the mean PAP and dividing by cardiac output.
Six-minute-walk distance (6MWD) and plasma B-type
natriuretic peptide (BNP) level were determined both
before PTPA and at the follow-up with the
hemodynamics.
INDICATIONS FOR PTPA. The indications of PTPA
(all items fulﬁlled) are the following: 1) mean
PAP >30 mm Hg and PVR >3.75 Wood units
(300 dyne/s/cm5), 2) New York Heart Association
functional class >2; and 3) understanding of the
interventional procedures and possible complications
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June 2012, the indication was changed concerning the
hemodynamic criteria: mean PAP >25 mm Hg if the
lesions are angiographically accessible, because most
patients with mean PAP >25 mm Hg are in New York
Heart Association functional class II and the safety
and effectiveness of PTPA are conﬁrmed based on our
initial experience.
Exclusion criteria for PTPA were serious com-
orbidity such as active infectious disease, severe
chronic obstructive pulmonary disease, advanced
hepatic disease, severe kidney disease, hemorrhagic
tendency, poorly controlled diabetes mellitus, or
uncontrolled hypertension. Patients who were unable
to lie on the treatment table during the procedure
were also excluded from the PTPA.
PROCEDURE OF PTPA. Coumadin was stopped for
3 days before the procedure and replaced by heparin,
which was controlled to keep activated partial
thromboplastin time within 60 to 80 s at the ward and
active clotting time within 250 to 300 s during the
procedure. Coumadin was restarted after PTPA and
adjusted within the optimal range when heparin was
stopped. In most cases, a catheter was inserted via
the femoral vein; however, when a patient had a ﬁlter
in the inferior vena cava, the catheter was inserted
through the right jugular vein. A balloon wedge-
pressure catheter was inserted into the main pulmo-
nary artery tract and replaced by a long spring
guidewire, before a 7- to 9-F coil-construction 80-cm-
long sheath was inserted into the main pulmonary
artery tract. A 6- to 8-F guide catheter was then
inserted through the sheath, and a 0.014-inch
guidewire was passed through the target lesion. The
target lesions were dilated by a 1.5- to 14.0-mm
monorail or over-the-wire balloon catheter. The bal-
loons were inﬂated by hand through an inﬂation de-
vice for 15 to 30 s until they were fully expanded.
Pulmonary arterial angiography of the lung
including target lesions was performed before each
session to select and determine the target lesions, but
not after the procedure. To check ﬂow appearance
and grade of ﬂow after angioplasty, selective angi-
ography of the treated vessels was performed through
a catheter engaged in the treated vessel. The balloon
size was determined by measurement of vessel
diameter by using the ruler to measure the vessel
diameter mainly on cine freeze-frame and occasion-
ally on intravascular ultrasound.
The enrolled patients had been treated with appro-
priate targeted drugs for pulmonary hypertension,
such as bosentan, ambrisentan, sildenaﬁl, tadalaﬁl,
or beraprost, before the procedure. Epoprostenol,treprostinil, and iloprost were not used in any of the
patients.
PTPA GUIDED WITH PRESSURE WIRE: THE DILATION
STRATEGY AND THE ENDPOINT OF THE PTPA SESSION.
A balloon dilation catheter was inserted through the
pressure wire (PrimeWire Prestige, Volcano Corpora-
tion, Rancho Cordova, California) when it passed
across the target lesion. When it did not, a 0.014-inch
guidewire was used with a microcatheter (2.6-F,
Finecross, Terumo, Tokyo, Japan) and exchanged to a
pressure wire. The PAP proximal and distal to the
target lesion and the ratio of the 2 pressures were
measured by the pressure wire. Balloon dilation was
performed ﬁrst using a relatively small-sized balloon,
and then the balloon size was sequentially increased
to obtain larger vascular diameter and greater pul-
monary ﬂow in the target lesion.
Since June 2012, the balloon dilation goal in terms
of effectiveness was to ﬁnish dilation when angio-
graphic pulmonary ﬂow grade (deﬁned in our previ-
ous report [3]) achieved grade 3. Since January 2013,
after we started using pressure wires, the goal
was changed to when the pressure ratio of distal
to proximal pressures across the target lesion, as
detected by pressure wire, was >0.8. Importantly,
however, the dilation was stopped, in terms of
avoidance of RPE, when the “Pd” value, the distal
mean PAP, indicated by the pressure wire after each
dilation reached 35 mm Hg (Figure 1) and when the
baseline mean PAP was >35 mm Hg. This is because
the development of RPE correlates with mean PAP
>35 mm Hg before angioplasty, and the median value
of mean PAP before angioplasty without any RPE is
33 mm Hg (1,3). Even if the stenosis remains angio-
graphically in the target lesion while the “Pd” values
improve to nearly 35 mm Hg, the PTPA procedures
should be stopped at this point and shifted to other
target lesions. The lesions with residual stenoses
should be dilated at the next sessions because the
improvement in the proximal PAP cannot be obtained
immediately but only several days later (2).
Since June 2012, to prevent RPE, the endpoint for
each PTPA session has been determined by PEPSI
(sum total change of pulmonary ﬂow grade scores 
baseline PVR [Wood units]) scores <35.4 because our
previous report (3) demonstrated that the negative
predictive value of RPE is 92.3% if the endpoint for
each PTPA session is determined by keeping the
PEPSI score <35.4.
COMPARISON OF THERAPEUTIC PARAMETERS, RPE,
AND VESSEL COMPLICATIONS. Fifty-four patients
(initial group) were enrolled during the period from
FIGURE 1 Pressure-Wire-Guided PTPA
Panels A and B show the pressure waveforms obtained by the pressure wire before percutaneous transluminal pulmonary angioplasty (PTPA).
The yellow pressure waveforms show the distal pressures of the target lesions and the red waveforms show the proximal pressures. The digit
indicated as “Pd” (green circles) is the mean pressure in the distal area across the target lesions. “FFR” value represents the pressure ratios of
the distal to proximal pressures across the target lesions. Since June 2012, the balloon dilation endpoints for each lesion in PTPA procedures
have been that angiographic pulmonary ﬂow grade achieves grade 3, and since January 2013, that the pressure ratios (indicated as FFR) of
distal to proximal pressures across the target lesions achieves >0.8. Importantly, however, the balloon dilations in PTPA procedures were
performed so as not to exceed the Pd value of 35 mm Hg. The angiogram shows the selective pulmonary angiography of the right pulmonary A2
segmental branches. Arrow A indicates typical stenotic lesion, and the pulmonary ﬂow grade in angiography was 0 (Online Video 1). Therefore,
there was severe pressure gradient (pressure ratio indicated by FFR: 0.26) between the proximal and distal sites across this lesion (A).
Meanwhile, the lesion indicated by arrow B was not viewed as obstructive by the angiography, but pulmonary ﬂow grade was 1, and the
pressure wire showed signiﬁcant pressure gradient (pressure ratio indicated by FFR: 0.29), which was almost the same level as the lesion
indicated by arrow A, between the proximal and distal sites across the lesion indicated by arrow B (B). Both of the distal pressure waveforms
(yellow waveforms) in A and B look like the waveforms of pulmonary arterial wedge pressure due to tight stenosis in the lesions (arrows A and
B). The angiography after balloon dilation revealed improved pulmonary ﬂows in both of the lesions (Online Video 2). These suggest that the
pressure wire is also useful to identify the sites of the signiﬁcant lesions that are not so clearly viewed in the angiography. ECG ¼ electro-
cardiogram; Pa ¼ the mean pressure in the proximal area of the target lesions.
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12 patients (middle group) were enrolled during the
period from June 2012 to December 2012 (middle
period). Finally, 37 patients (latest group) were
enrolled during the period from January 2013 to
December 2013 (latest period). One-hundred forty
PTPA sessions were performed during the initial
period without the guidance of PEPSI and pressure
wire (no-guidance sessions). Then, 65 PTPA sessions
were performed during the middle period with guid-
ance of PEPSI (PEPSI-guided sessions), and 145 PTPA
sessions during the latest period with guidance of
both pressure wire and PEPSI (pressure-wire-and-
PEPSI-guided sessions). The hemodynamic parame-
ters, 6MWD, and BNP at baseline just before the ﬁrst
PTPA and at follow-up were compared among these3 groups. The frequencies of complications of RPE and
vascular injuries were compared among the 3 groups.
STATISTICAL ANALYSIS. All data are presented as
median (interquartile range). Signiﬁcant differences
were determined using the Mann-Whitney U test,
Wilcoxon matched-pairs signed rank test, Kruskal-
Wallis test, or Dunn multiple comparisons test,
as appropriate. Differences in frequencies were
analyzed using the chi-square test. Correlation be-
tween pulmonary ﬂow grade and the ratio of pressure
difference was analyzed using the Spearman rank
correlation coefﬁcient. The hemodynamic parame-
ters, 6MWD, and BNP at baseline just before the ﬁrst
procedure and at the time of follow-up after the last
PTPA session were compared among the 3 groups by
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 7 , N O . 1 1 , 2 0 1 4 Inami et al.
N O V E M B E R 2 0 1 4 : 1 2 9 7 – 3 0 6 Pressure-Wire-Guided PTPA
13012-way repeated-measures analysis of variance
and Turkey or Sidak multiple comparisons test, as
appropriate. Although the number of enrolled pa-
tients was 103, follow-up analysis was performed in
83 patients (53, 12, and 18 patients in the initial,
middle, and latest groups, respectively), in whom the
follow-up examinations had been performed for a
total observation period of >30 days. No adjustments
were made for multiple sessions within patients in
the session-wise analyses. A value of p < 0.05 was
considered statistically signiﬁcant.
RESULTS
CLINICAL IMPROVEMENT BY PTPA. The baseline
characteristics of the enrolled 103 patients and
3 groups are detailed in Table 1. The numbers of PTPA
sessions performed per patient was the lowest in the
latest among the 3 groups [median: 3.5 (interquartile
range [IQR]: 2.0 to 4.0] sessions vs. 4.0 (IQR: 3.3 to 5.0)
sessions vs. 2.0 (IQR: 2.0 to 4.0) sessions; initial group
vs. middle group vs. latest group]. The number
of treated vessels per patient tended to be lowest in
the latest among the 3 groups without statisticalTABLE 1 Baseline Characteristics in Each Group
Enrolled Patients
(N ¼ 103)
Age, yrs 65 (53–72)
Female/male 79/24
NYHA functional class, I/II/III/IV 0/13/74/16
Previous pulmonary endarterectomy 11
Mean RAP, mm Hg 5 (3–8)
Mean PAP, mm Hg 41 (33–48)
PVR, Wood units 8.6 (5.8–12.3)
CI, l/min/m2 2.5 (2.1–2.8)
PAWP, mm Hg 8 (6–11)
SvO2, % 66.0 (61.0–71.0)
6MWD, m 348 (258–420)
(n ¼ 93)
BNP, pg/ml 94 (42–232)
Total PTPA sessions 350
January 2009 to June 2012 140 (no-guidance sessions)
July 2012 to December 2012 65 (PEPSI-guided sessions)
January 2013 to December 2013 145 (pressure-wire-and-
PEPSI-guided sessions)
PTPA session per patient 3.0 (2.0–4.0)
Total dilated vessels 1,302
January 2009 to June 2012 525
July 2012 to December 2012 223
January 2013 to December 2013 554
Dilated vessels per patient 11 (7–17)
Values are n or median (interquartile range). *p < 0.05 vs. initial group; †p < 0.01 vs.
6MWD ¼ 6-minute walk distance; BNP ¼ B-type natriuretic peptide; CI ¼ cardiac inde
pulmonary arterial wedge pressure; PEPSI ¼ Pulmonary Edema Predictive Scoring Index;
resistance; RAP ¼ right atrial pressure; SvO2 ¼ mixed venous oxygen saturation.signiﬁcance (median: 12.0 [IQR: 8.0 to 19.3] vessels vs.
15.0 [IQR: 9.3 to 18.0] vessels vs. 9.0 [IQR: 6.5 to 14.0]
vessels; initial group vs. middle group vs. latest
group). The size of the vessels intervened ranged from
2.0 to 14.0 mm. The percentage of 100% occluded le-
sions such as complete obstruction and pouch defect
was 9.6%, but the vessel sizes of these 100%-occluded
lesions were <8.0 mm. The recanalization success rate
of the 100%-occluded lesions was 70.4%.
The follow-up analysis, which included 83 pa-
tients, showed that the average observation period
from the ﬁrst procedure to the last follow-up was 14.0
(IQR: 7.6 to 21.9) months, and the average number of
PTPA sessions per a patient was 3.0 (IQR: 2.0 to 4.0).
A comparison of the examinations at baseline with
those at follow-up is presented in Figure 2. The right-
sided heart catheterization demonstrated a signiﬁ-
cant improvement in hemodynamic parameters
(mean right atrial pressure: 5 [IQR: 3 to 7] mm Hg vs. 3
[IQR: 2 to 5] mm Hg; mean PAP: 41 [IQR: 34 to 47]
mm Hg vs. 21 [IQR: 18 to 28] mm Hg; median PVR: 8.7
[IQR: 6.1 to 13.3] Wood units vs. 2.7 [IQR: 2.0 to 4.2]
Wood units; and median cardiac index: 2.5 [IQR: 2.1 to
2.9] l/min/m2 vs. 2.9 [IQR: 2.4 to 3.5] l/min/m2;Initial Group
(n ¼ 54)
Middle Group
(n ¼ 12)
Latest Group
(n ¼ 37)
64 (55–70) 60 (41–70) 70 (53–76)
41/13 10/2 28/9
0/4/40/10 0/2/9/1 0/7/24/6
6 3 2
5 (3–7) 4 (2–7) 6 (3–8)
43 (37–52) 42 (32–43) 37 (31–48)
9.2 (6.9–15.0) 6.5 (5.8–14.5) 7.7 (4.9–11.3)
2.5 (1.8–2.9) 2.4 (1.9–2.8) 2.5 (2.2–2.8)
7 (5–10) 9 (5–11) 8 (6–12)
66.0 (59.7–72.4) 64.7 (61.3–69.7) 66.2 (62.1–69.2)
360 (278–407)
(n ¼ 50)
369 (352–457)
(n ¼ 11)
327 (250–428)
(n ¼ 32)
126 (54–390) 58 (33–181) 61 (39–150)
201 49 100
140 0 0
37 (patients, n ¼ 19) 28 0
24 (patients, n ¼ 13) 21 (patients, n ¼ 8) 100
3.5 (2.0–4.0) 4.0 (3.3–5.0) 2.0 (2.0–4.0)*†
751 168 383
525 0 0
135 88 0
91 80 383
12 (8–19) 15 (9–18) 9 (7–14)
middle group.
x; NYHA ¼ New York Heart Association; PAP ¼ pulmonary arterial pressure; PAWP ¼
PTPA ¼ percutaneous transluminal pulmonary angioplasty; PVR ¼ pulmonary vascular
FIGURE 2 Therapeutic Efﬁcacy of PTPA in All the Patients Enrolled
Hemodynamic changes in the mean right atrial pressure (RAP) (A), the mean pulmonary arterial pressure (PAP) (B), the pulmonary vascular
resistance (PVR) (C), the cardiac index (CI) (D), and the plasma B-type natriuretic peptide (BNP) (E) and 6-min walk distance (6MWD) (F) at
follow-up after percutaneous transluminal pulmonary angioplasty (PTPA). All hemodynamic parameters, BNP, and 6MWD were signiﬁcantly
improved at follow-up. Bars denote medians, boxes denote interquartile ranges, whiskers denote ranges excluding statistical outliers
(open circles) (>1.5 box lengths from either the 25th or 75th percentiles). *p < 0.0001 versus baseline.
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Plasma BNP was signiﬁcantly decreased after PTPA
(median: 94.5 [IQR: 41.7 to 269.5] pg/ml vs. 33.7 [IQR:
15.8 to 59.2] pg/ml, p < 0.0001). The 6MWD was
signiﬁcantly lengthened at the follow-up from 360
(IQR: 281 to 430) m to 420 (IQR: 350 to 510) m
(p < 0.0001, n ¼ 69).
Comparisons among the 3 groups are shown in
Figure 3. The average observation periods from theﬁrst
procedure to the last follow-up were 9.3 (IQR: 6.3 to
14.1)months, 4.8 (IQR: 3.7 to 6.8)months, and 6.4 (IQR:
4.0 to 7.1) months in the initial, middle, and latest
groups, respectively. The average number of PTPA
sessions per patient was 2.0 (IQR: 2.0 to 4.0), 2.0 (IQR:
2.0 to 3.0), and 2.0 (IQR: 2.0 to 3.3) in the initial,
middle, and latest groups, respectively, without
statistically signiﬁcant differences. The degree of
improvement in hemodynamics, the levels of BNP, and
prolongation of 6MWDwere not signiﬁcantly differentamong the 3 groups. Additionally, the average reduc-
tion rate of mean PAP in patients with baseline mean
PAP >40 mm Hg in the latest group was 38.7% (IQR:
27.5% to 48.8%), and that in patients with mean PAP
<40 mm Hg was 28.5% (15.4% to 42.2%).
MORTALITY AND VESSEL INJURIES. Among 103 pa-
tients enrolled, 1 patient died in the initial group. The
patient had severe right heart failure before PTPA and
developed pulmonary hemorrhage as a complication
because of wire perforation during the procedure.
Although the perforation was completely sealed, right
heart failurewas exacerbated and caused the patient to
die 2 days after the session. Therefore, the mortality
associated with the PTPA procedure was 0.97%.
Table 2 shows the baseline characteristics of
session-based subgroups divided by the methods
of guidance. Among the total of 350 sessions, a
dissection of the targeted pulmonary artery just
FIGURE 3 A Comparison of Therapeutic Efﬁcacy Among the 3 Groups
Hemodynamic changes in mean RAP (A), mean PAP (B), PVR (C), and CI (D) and plasma BNP (E) and 6MWD (F) at the follow-up after PTPA in
the 3 groups (initial, middle, and latest). Bars denote medians, boxes denote interquartile ranges, whiskers denote ranges excluding statistical
outliers (open circles) (>1.5 box lengths from either the 25th or 75th percentiles). Abbreviations as in Figures 1 and 2.
TABLE 2 Baseline Characteristics in Each Subgroup
No-Guidance
Sessions
(n ¼ 140)
PEPSI-Guided
Sessions (n ¼ 65)
Pressure-Wire-
and-PEPSI-Guided
Sessions (n ¼ 145)
Period 1/2009–6/2012 7/2012–12/2012 1/2013–12/2013
Mean RAP before session, mm Hg 4 (3–6) 4 (2–6) 5 (3–7)
Mean PAP before session, mm Hg 38 (30–45) 29 (23–36)* 32 (26–38)*
PVR before session, Wood units 7.2 (4.6–10.9) 4.8 (3.0–6.5)* 5.3 (3.4–7.7)*
CI before session, l/min/m2 2.5 (2.2–3.1) 2.6 (2.2–3.1) 2.7 (2.4–3.2)
PAWP before session, mm Hg 8 (6–9) 8 (6–10) 9 (6–12)*
SvO2 before session, % 67.6 (63.2–72.7) 68.2 (62.6–72.5) 68.2 (63.9–72.2)
Dilated vessels 4 (2–5) 3 (2–4) 4 (2–5)
Values are median (interquartile range). *p < 0.01 vs. no-guidance sessions.
Abbreviations are deﬁned in Table 1.
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1303after balloon dilation, without extravascular leaks,
occurred in 7 sessions (5 in the no-guidance sessions
and 2 in the PEPSI-guided sessions), but the hemo-
dynamics did not signiﬁcantly change by dissections,
and pulmonary angiography after 1 week revealed
spontaneous disappearance of the dissections in all
the cases. Extravascular leaks occurred just after the
balloon dilation in 28 sessions (15 in the no-guidance
sessions, 3 in the PEPSI-guided sessions, and 10 in the
pressure-wire-and-PEPSI-guided sessions), in which
they were stopped by prolonged low-pressure dila-
tion of the balloon in 15 sessions (6 in the no-guidance
sessions including the 1 deceased patient, 2 in the
PEPSI-guided sessions, and 7 in the pressure-wire-
and-PEPSI-guided sessions), by insertion of the
covered stent in 1 session without the guide, by
coiling in 1 session without the guide, and sponta-
neously in 11 sessions (7 sessions without guid-
ance, 1 in the PEPSI-guided sessions, and 3 in the
pressure-wire-and-PEPSI-guided sessions). In sum-
mary, the total rate of angiographic complications
was 14.3%, 7.7%, and 6.9% in the no-guidance,PEPSI-guide, and both pressure-wire-and-PEPSI-
guide sessions, respectively.
FREQUENCY OF REPERFUSION PULMONARY EDEMA.
Table 3 shows the distributions of graded RPE. RPE
of grade 1 or 2, which means no clinically critical
RPE, was statistically higher in the PEPSI-guided and
TABLE 3 Classiﬁcation and Frequency of Reperfusion Pulmonary Edema
Grade
Deﬁnition of Graded Reperfusion
Pulmonary Edema
Total PTPA
Sessions
No-Guided
Sessions
PEPSI-Guided
Sessions
Pressure-Wire-
and-PEPSI-Guided
Sessions
1 No signiﬁcant recognition of reperfusion pulmonary edema
on chest x-ray
271 (77.4) 87 (62.1) 59 (90.8) 125 (86.2)
2 Mild or small reperfusion pulmonary edema on chest x-ray, but
spontaneous improvement with only a small increase in inhalation
of oxygen concentration for a few days
58 (16.6) 35 (25.0) 5 (7.7) 18 (12.4)
3 Moderate reperfusion pulmonary edema on chest x-ray that needed
elevated concentration of oxygen administered via oxygen mask
to maintain arterial saturation at optimal level
12 (8.6) 9 (6.4) 1 (1.5) 2 (1.4)
4 Moderate to severe reperfusion pulmonary edema on chest
x-ray requiring noninvasive positive pressure ventilation with
high-concentration oxygen inhalation
7 (2.0) 7 (5.0) 0 (0) 0 (0)
5 Extremely severe reperfusion pulmonary edema on chest
x-ray requiring artiﬁcial ventilation
2 (0.6) 2 (1.4) 0 (0) 0 (0)
Values are n (%).
Abbreviations as in Table 1.
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1304pressure-wire-and-PEPSI-guided sessions (98.5% and
98.6%, respectively). Meanwhile, RPE of grade 4
or higher, which means clinically critical RPE
requiring noninvasive positive pressure ventilation or
artiﬁcial respiration, in the no-guidance sessions,
PEPSI-guided sessions, and pressure-wire-and-PEPSI-
guided sessions occurred in 9 (6.4%), 0 (0%), and
0 (0%) sessions, respectively, with statistically sig-
niﬁcant differences.
FLUOROSCOPY TIME AND X-RAY EXPOSURE.
Median ﬂuoroscopy time in the no-guidance, PEPSI-
guided, and pressure-wire-and-PEPSI-guided ses-
sions were 74.1 (IQR: 57.9 to 89.9) min, 79.8 (IQR: 63.3
to 94.3) min, and 74.8 (IQR: 59.0 to 91.5) min,
respectively. There was no signiﬁcant difference in
ﬂuoroscopy time among the 3 session-based sub-
groups. Meanwhile, median x-ray exposure in the
no-guidance, PEPSI-guided, and pressure-wire-and-
PEPSI-guided sessions were 1,531 (IQR: 765 to 2,621)
mGy, 1,102 (IQR: 565 to 1,890) mGy, and 953 (IQR: 527
to 1,784) mGy, respectively. X-ray exposure in PEPSI-
guided and pressure-wire-and-PEPSI-guided sessions
were signiﬁcantly lower than in the no-guidance
sessions (no-guidance vs. PEPSI-guided sessions,
p < 0.05; no-guided vs. pressure-wire-and-PEPSI-
guided sessions, p < 0.001). Radiation-induced
injury (of any kind) did not occur in any session-
based subgroup.
CORRELATION BETWEEN PULMONARY FLOW GRADE
SCORES AND THE PRESSURE RATIOS ACROSS THE
LESIONS. In the pressure-wire-and-PEPSI-guided ses-
sions, we analyzed the correlation between pul-
monary ﬂow grade scores and the pressure ratios
across the lesions detected by the pressure wire. Weperformed 891 measurements of the pressure ratios in
493 of 554 target vessels with pulmonary ﬂow grades
0 to 3 in 145 pressure-wire-and-PEPSI-guided sessions.
Figure 4 shows the correlation between the pulmonary
ﬂow grade score and the pressure ratios, demon-
strating strong correlation (R ¼ 0.90, p < 0.0001).
Furthermore, the distributions of pressure ratios in
each pulmonary ﬂow grade were 0.20 (IQR: 0.14 to
0.30;minimum: 0.03, maximum: 0.63), 0.30 (IQR: 0.24
to 0.38; minimum: 0.06, maximum: 0.78), 0.60 (IQR:
0.50 to 0.70; minimum: 0.30, maximum: 0.88), and
0.90 (IQR: 0.81 to 1.00; minimum: 0.54, maxi-
mum: 1.00) in pulmonary ﬂow grades 0, 1, 2, and 3,
respectively.
DISCUSSION
In the present study, we demonstrated the following:
1) the PTPA technique using pressure wire and PEPSI
attained more efﬁcient clinical results, meaning that
the same results were obtained by dilating fewer
lesions and performing fewer PTPA sessions because
the pressure wire can detect pressure gradients across
the lesions objectively and quantitatively, leading to
a reduction of insufﬁcient dilation left; and 2) the
guided technique with both the pressure wire and
PEPSI contributed to the establishment of PTPA as the
low-risk, promising strategy for CTEPH.
On the basis of the report of Feinstein et al. (1) and
our initial PTPA experience, eliminating RPE has been
an essential component of developing a safe PTPA
approach. In fact, Feinstein et al. (1) reported that
about 60% of the treated patients developed RPE af-
ter the procedures. RPE has been the most important
complication in pulmonary angioplasty, which
FIGURE 4 Correlation Between Pulmonary Flow Grade
Score and the Ratio of Proximal and Distal Pressures of the
Target Lesions
Pulmonary ﬂow grade scores were strongly correlated with the
pressure ratios. The median distributions of the pressure ratios in
each pulmonary ﬂow grade were 0.20 (IQR: 0.14 to 0.30; mini-
mum: 0.03, maximum: 0.63), 0.30 (IQR: 0.24 to 0.38; minimum:
0.06, maximum: 0.78), 0.60 (IQR: 0.50 to 0.70; minimum: 0.30,
maximum: 0.88), and 0.90 (IQR: 0.81 to 1.00; minimum: 0.54,
maximum: 1.00) in pulmonary ﬂow grades 0, 1, 2, and 3,
respectively. Bars denote medians, boxes denote IQRs, whiskers
denote ranges excluding statistical outliers (open circles)
(>1.5 box lengths from either the 25th or 75th percentiles).
IQR ¼ interquartile range.
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1305sometimes leads to grave morbidity and mortality.
With PTPA, most of the lesions cannot be treated at
once because when each lesion is dilated, it is
exposed to high PAP. In contrast, with pulmonary
endarterectomy, the majority of the lesions are
removed in 1 procedure. This difference may explain
why the incidence of reperfusion lung injury has been
higher with PTPA than with pulmonary endarterec-
tomy in the past. Importantly, these ﬁndings pro-
vided us with the inspiration that demonstrate that it
is crucial to conquer RPE to control and suppress the
pressure levels distal to the target lesions to certain
levels after dilation during the PTPA procedure.
The pressure wire technique has been used in
percutaneous coronary intervention with great suc-
cess in terms of determining the lesions and con-
ﬁrming results (12). Thus, this technique was used in
PTPA procedures in our study. Balloon dilation of the
target lesions was stopped when pressure levels
distal to the target lesions reached nearly 35 mm Hg
if baseline mean PAP was more than this level. The
criteria of 35 mm Hg was adopted because develop-
ment of RPE correlates with mean PAP >35 mm Hg
before angioplasty, and the median value of mean
PAP before angioplasty without any RPE was 33
mm Hg (1,3). Neither the PEPSI-guided nor pressure-
wire-and-PEPSI-guided sessions induced any clini-
cally critical RPE without the use of a noninvasive
positive pressure ventilator or mechanical ventilator.
PEPSI is a promising predictor to avoid signiﬁcant
RPE (3). However, PEPSI is not an objective method,
and a combination of the PEPSI score determined
subjectively and the pressure-wire technique deter-
mined objectively can avoid signiﬁcant RPE with
higher probability. Additionally, the total rate of
angiographic complications was lower in the PEPSI-
guided and pressure-wire-and-PEPSI-guided ses-
sions than in the no-guidance sessions. One of the
important beneﬁts of the pressure-wire technique is
that the pressure levels distal to the target lesions can
be controlled; another is that overdilation of the
target vessels by balloon catheters can also be avoi-
ded. This might contribute to the lowest rate of
angiographic complications in the pressure-wire-and-
PEPSI-guided sessions. These ﬁndings suggest that
the pressure-wire technique may have advantages in
reducing the risk of the vessel injuries during the
procedure as well as the risk of signiﬁcant RPE
afterward.
In our PTPA procedures, the target lesions located
in segmental, subsegmental, and more distal pulmo-
nary arteries and the size of the vessels intervened
was 2.0 to 14.0 mm (the vessel sizes of 100%-occluded
lesions were <8.0 mm). The degrees of hemodynamicimprovement were not signiﬁcantly different among
the initial, middle, and latest groups. Furthermore,
the number of performed PTPAs and the number of
treated target lesions were lowest in the latest group
compared with those in the other 2 groups. These
ﬁndings suggest that the pressure-wire technique
attained the better hemodynamic improvement in
fewer target lesions treated and fewer PTPAs per-
formed. In the pressure-wire-and-PEPSI-guided ses-
sions, the targeted endpoint of balloon dilation for
each lesion was to achieve >0.8 of the pressure ratio
detected by the pressure wire. Pulmonary ﬂow grade
scores and the pressure ratios were signiﬁcantly
correlated in this study. Importantly, however, the
pressure ratios in each pulmonary ﬂow grade showed
wide distributions. For example, the median pressure
ratios in pulmonary ﬂow grade 3 were 0.90 (IQR: 0.81
to 1.00; minimum: 0.54, maximum 1.00) in this study.
These ﬁndings imply that if pulmonary ﬂow grade 3 is
obtained after dilation of the target lesions by balloon
catheters, there are some cases with pulmonary ﬂow
grade 3 in which pressure ratios were <0.8, meaning
that signiﬁcant stenosis remained in these lesions.
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across the target lesions and the targeted endpoint to
achieve >0.8 of the pressure ratios might reduce the
number of insufﬁciently dilated lesions left with
pulmonary ﬂow grade 3. It also shows why PTPA
yields more efﬁcient results in the pressure-wire-and-
PEPSI-guided PTPA sessions.
Furthermore, the pressure wire was useful to
identify abnormal lesions that were not so clearly
viewed by angiography. In Figure 1, the lesion indi-
cated by arrow A was clearly viewed on angiogram,
and pulmonary ﬂow grade was 0 before PTPA. The
lesion indicated by arrow B was not so clearly viewed
by angiography, but pulmonary ﬂow grade was 1, and
the pressure wire was useful in identifying the sig-
niﬁcant stenotic lesion in this case. Online Video 1
shows angiography of these lesions before PTPA, and
Online Video 2 shows angiography after PTPA,
demonstrating the improved angiographic ﬂow of
these lesions. These ﬁndings demonstrate that the
pressure wire was useful for identifying the signiﬁcant
lesions precisely and to avoid overlooking the lesions
that were not so clearly observed by angiography.
STUDY LIMITATIONS. This was a retrospective case-
control study. The number of patients enrolled was
not large, and the observation period and number of
patients distributed among the 3 groups were
different. Furthermore, because the possible impact
of a learning curve cannot be ruled out, there is a
possibility that the low rate of complications in thelatest group may be related not only to pressure-wire-
guidance but also to greater operator experience.
In addition, because the inclusion criteria were
changed during the study, there is a possibility that
selection process affected the results. To demonstrate
usefulness and efﬁciency of the pressure-wire-and-
PEPSI-guided PTPA procedure, a large-scaled collab-
orative prospective study in the near future is
strongly desired.CONCLUSIONS
There were no clinically critical RPE and vessel
injuries when PTPA was performed using the
pressure-wire-and-PEPSI-guided technique. Pressure
wire was efﬁcient in obtaining good clinical results.
Therefore, the ﬁndings in this study indicate that
pressure-wire-and-PEPSI-guided PTPA is effective in
CTEPH, improves procedural success rates, and re-
duces the risk of the procedure.
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